Please use this identifier to cite or link to this item:
|Title:||Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil.|
|Citation:||J CLIN PSYCHOPHARMACOL, 2009, 29 (4), pp. 387-390|
|Abstract:||Olfactory dysfunction, impaired odor identification in particular, is known to occur in Alzheimer disease (AD). The entorhinal cortex and the olfactory bulb, critical areas for olfactory function, are rich in acetylcholine, the neurotransmitter implicated in AD pathology and treatment. In view of the common anatomical substrate, we aimed to determine whether performance on an olfaction test can be used as a clinical marker for monitoring the efficacy of donepezil in elderly people with AD.|
|Appears in Collections:||Published Articles, Dept. of Health Sciences|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.